AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$667M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$433M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$415M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$339M |
| 5 |
Regency Centers
REG
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$467M |
| 2 |
Crown Castle
CCI
|
+$343M |
| 3 |
Citigroup
C
|
+$238M |
| 4 |
Starbucks
SBUX
|
+$231M |
| 5 |
Gartner
IT
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.11% |
| 2 | Healthcare | 15.25% |
| 3 | Financials | 15.1% |
| 4 | Consumer Discretionary | 11.4% |
| 5 | Industrials | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
1926
Tvardi Therapeutics
TVRD
$19.7M
| $1.69M | ﹤0.01% |
3,603
+2,389
| +197% | +$1.54M |
|
|
JCAP
1927
DELISTED
Jernigan Capital, Inc.
JCAP
| $1.69M | ﹤0.01% |
85,035
+22,550
| +36% | +$459K |
|
1928
Collegium Pharmaceutical
COLL
$1.15B
| $1.68M | ﹤0.01% |
98,050
+60,850
| +164% | +$1.04M |
|
1929
Huron Consulting
HURN
$2.41B
| $1.67M | ﹤0.01% |
32,600
-460
| -1% | -$23.4K |
|
|
MIC
1930
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $1.67M | ﹤0.01% |
45,675
+1,730
| +4% | +$69.3K |
|
|
TIVO
1931
DELISTED
Tivo Inc
TIVO
| $1.67M | ﹤0.01% |
177,435
-2,691
| -1% | -$29K |
|
1932
US Physical Therapy
USPH
$1.2B
| $1.66M | ﹤0.01% |
16,207
-100
| -0.6% | -$11.1K |
|
1933
Universal Corp
UVV
$1.31B
| $1.66M | ﹤0.01% |
30,614
| – | – |
|
|
EGRX
1934
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.66M | ﹤0.01% |
41,160
-2,660
| -6% | -$137K |
|
|
RAVN
1935
DELISTED
Raven Industries Inc
RAVN
| $1.65M | ﹤0.01% |
45,688
-800
| -2% | -$33.3K |
|
1936
Enerpac Tool Group
EPAC
$1.83B
| $1.65M | ﹤0.01% |
78,644
-7,000
| -8% | -$171K |
|
|
DCH
1937
Dauch Corp
DCH
$1.34B
| $1.64M | ﹤0.01% |
148,131
+4,380
| +3% | +$58.6K |
|
|
SGMO
1938
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.64M | ﹤0.01% |
143,041
| – | – |
|
|
HF
1939
DELISTED
HFF Inc.
HF
| $1.64M | ﹤0.01% |
49,500
-818
| -2% | -$30.4K |
|
1940
First Bank
FRBA
$464M
| $1.64M | ﹤0.01% |
135,149
+16,011
| +13% | +$192K |
|
|
SPTN
1941
DELISTED
SpartanNash
SPTN
| $1.64M | ﹤0.01% |
95,360
+9,680
| +11% | +$176K |
|
1942
Pricesmart
PSMT
$5.98B
| $1.64M | ﹤0.01% |
27,676
-300
| -1% | -$20.7K |
|
1943
Titan Machinery
TITN
$396M
| $1.64M | ﹤0.01% |
124,440
-9,980
| -7% | -$148K |
|
|
VRTU
1944
DELISTED
Virtusa Corporation
VRTU
| $1.64M | ﹤0.01% |
38,413
+1,300
| +4% | +$59.4K |
|
|
LTRPA
1945
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.64M | ﹤0.01% |
102,904
-206,600
| -67% | -$3.31M |
|
1946
United Parks & Resorts
PRKS
$2.1B
| $1.63M | ﹤0.01% |
73,900
-8,720
| -11% | -$233K |
|
1947
First Interstate BancSystem
FIBK
$3.69B
| $1.63M | ﹤0.01% |
44,524
| – | – |
|
1948
PRA Group
PRAA
$663M
| $1.62M | ﹤0.01% |
66,652
-4,000
| -6% | -$119K |
|
|
IMGN
1949
DELISTED
Immunogen Inc
IMGN
| $1.62M | ﹤0.01% |
337,444
+122,241
| +57% | +$742K |
|
1950
Enpro
NPO
$6.63B
| $1.62M | ﹤0.01% |
26,935
-100
| -0.4% | -$6.63K |
|
Similar funds
AllianceBernstein's Q4 2018 Portfolio in Review
As of Q4 2018, AllianceBernstein held 3,227 positions worth $135B, down 12% from $153B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
AllianceBernstein deployed $4.13B of net new capital in Q4 2018, opening 89 new positions and adding to 1,675 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 5,205,127 shares worth $435M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Crown Castle, an estimated $343M trimmed.
- AllianceBernstein's largest Q4 2018 buy was iShares 1-3 Year Treasury Bond ETF: 5,205,127 shares worth $435M.
- AllianceBernstein added most to Microsoft in Q4 2018, an estimated $667M increase.
- AllianceBernstein's biggest Q4 2018 reduction was Crown Castle, cutting an estimated $343M.
- AllianceBernstein fully exited Aetna Inc in Q4 2018, selling an estimated $467M.
- AllianceBernstein's ten largest holdings make up 17% of its $135B portfolio in Q4 2018.
- AllianceBernstein opened 89 new positions and closed 131 in Q4 2018.
- AllianceBernstein's portfolio value fell 12% quarter-over-quarter to $135B.
Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.